Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)
Italy · Delayed Price · Currency is EUR 1.125
+0.005 (0.45%)
At close: Jul 28, 2026
BIT:ERFO Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 9.96 | 6.34 | 5.42 | 5.02 | 5.1 | |
Revenue Growth | 57.11% | 16.96% | 8.02% | -1.71% | 21.54% |
Cost of Revenue | -2.94 | -1.68 | 1.56 | 1.32 | 1.37 |
Gross Profit | 12.9 | 8.01 | 3.86 | 3.7 | 3.73 |
Selling, General & Admin | -3.41 | -2.05 | 2.3 | 1.93 | 1.68 |
Depreciation & Amortization Expenses | - | - | 0.65 | 0.62 | 0.44 |
Other Operating Expenses | -0.2 | -0.14 | 0.11 | 0.11 | 0.05 |
Total Operating Expenses | -3.6 | -2.18 | 3.06 | 2.66 | 2.16 |
Operating Income | 0.99 | 0.52 | 0.79 | 1.04 | 1.57 |
Interest Income | - | - | 0.01 | 0 | 0 |
Interest Expense | - | - | -0.03 | -0.04 | -0.02 |
Other Non-Operating Income (Expense) | -0 | -0 | -0 | - | -0.01 |
Total Non-Operating Income (Expense) | -0 | -0 | -0.02 | -0.04 | -0.02 |
Pretax Income | 1.04 | 0.53 | 0.78 | 1 | 1.54 |
Provision for Income Taxes | - | - | 0.19 | 0.25 | 0.39 |
Net Income | 0.74 | 0.35 | 0.58 | 0.75 | 1.16 |
Minority Interest in Earnings | 0.36 | -0.01 | - | - | - |
Net Income to Common | 0.38 | 0.37 | 0.58 | 0.75 | 1.16 |
Net Income Growth | 3.99% | -37.07% | -22.68% | -34.85% | 1.54% |
Shares Outstanding (Basic) | 9 | 9 | 9 | 9 | 2 |
Shares Outstanding (Diluted) | 9 | 9 | 9 | 9 | 2 |
Shares Change | 0.60% | -5.56% | - | 500.00% | - |
EPS (Basic) | 0.04 | 0.04 | 0.07 | 0.08 | 0.77 |
EPS (Diluted) | 0.04 | 0.04 | 0.07 | 0.08 | 0.77 |
EPS Growth | 11.57% | -42.86% | -12.50% | -89.63% | - |
Free Cash Flow | 0.92 | 1.24 | 0.96 | 0.27 | 2.06 |
Free Cash Flow Growth | -25.97% | 28.84% | 251.48% | -86.72% | 57.03% |
Free Cash Flow Per Share | 0.11 | 0.15 | 0.11 | 0.03 | 1.38 |
Dividends Per Share | - | - | 0.060 | - | - |
Dividend Growth | - | - | - | - | - |
Gross Margin | 129.50% | 126.43% | 71.19% | 73.71% | 73.15% |
Operating Margin | 9.96% | 8.26% | 14.66% | 20.68% | 30.74% |
Profit Margin | 7.40% | 5.57% | 10.76% | 15.03% | 22.68% |
FCF Margin | 9.23% | 19.58% | 17.77% | 5.46% | 40.41% |
EBITDA | 1.91 | 1.21 | 1.44 | 1.65 | 2.01 |
EBITDA Margin | 19.13% | 19.12% | 26.61% | 32.98% | 39.33% |
EBIT | 0.99 | 0.52 | 0.79 | 1.04 | 1.57 |
EBIT Margin | 9.96% | 8.26% | 14.66% | 20.68% | 30.74% |
Effective Tax Rate | 0.00% | 0.00% | 24.83% | 24.53% | 25.07% |